KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets (2018 - 2025)

Historic Return on Assets for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 0.54%.

  • Aquestive Therapeutics' Return on Assets fell 2300.0% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year decrease of 2300.0%. This contributed to the annual value of 0.56% for FY2024, which is 4200.0% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Return on Assets of 0.54% as of Q3 2025, which was down 2300.0% from 0.66% recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Return on Assets high stood at 0.13% for Q4 2023, and its period low was 1.31% during Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.56% (2023), whereas its average is 0.68%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 11000bps in 2023, then tumbled by -4600bps in 2025.
  • Aquestive Therapeutics' Return on Assets (Quarter) stood at 1.11% in 2021, then increased by 10bps to 1.0% in 2022, then surged by 87bps to 0.13% in 2023, then plummeted by -210bps to 0.42% in 2024, then fell by -28bps to 0.54% in 2025.
  • Its Return on Assets stands at 0.54% for Q3 2025, versus 0.66% for Q2 2025 and 0.53% for Q1 2025.